Abstract:Breast cancer is the leading cause of cancer-related mortality in women worldwide, with an estimated 1.7 million new cases and 522,000 deaths around the world in 2012 alone. Cancer stem cells (CSCs) are essential for tumor reoccurrence and metastasis which is the major source of cancer lethality. G protein-coupled receptor chemokine (C-X-C motif) receptor 4 (CXCR4) is critical for tumor metastasis. However, stromal cell-derived factor 1 (SDF-1)/CXCR4-mediated signaling pathways in breast CSCs are largely unknown. Using isotope reductive dimethylation and large-scale MS-based quantitative phosphoproteome analysis, we examined protein phosphorylation induced by SDF-1/CXCR4 signaling in breast CSCs. We quantified more than 11,000 phosphorylation sites in 2,500 phosphoproteins. Of these phosphosites, 87% were statistically unchanged in abundance in response to SDF-1/CXCR4 stimulation. In contrast, 545 phosphosites in 266 phosphoproteins were significantly increased, whereas 113 phosphosites in 74 phosphoproteins were significantly decreased. SDF-1/CXCR4 increases phosphorylation in 60 cell migration- and invasion-related proteins, of them 43 (>70%) phosphoproteins are unrecognized. In addition, SDF-1/CXCR4 upregulates the phosphorylation of 44 previously uncharacterized kinases, 8 phosphatases, and 1 endogenous phosphatase inhibitor. Using computational approaches, we performed system-based analyses examining SDF-1/CXCR4-mediated phosphoproteome, including construction of kinase-substrate network and feedback regulation loops downstream of SDF-1/CXCR4 signaling in breast CSCs. We identified a previously unidentified SDF-1/CXCR4-PKA-MAP2K2-ERK signaling pathway and demonstrated the feedback regulation on MEK, ERK1/2, δ-catenin, and PPP1Cα in SDF-1/CXCR4 signaling in breast CSCs. This study gives a system-wide view of phosphorylation events downstream of SDF-1/CXCR4 signaling in breast CSCs, providing a resource for the study of CSC-targeted cancer therapy.

Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesis

Functional Characterization of FBXL7 As a Novel Player in Human Cancers

Targeting SCF E3 Ligases for Cancer Therapies

Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor.

Molecular insights and clinical implications for the tumor suppressor role of SCFFBXW7 E3 ubiquitin ligase

FBW7-mediated ubiquitination and degradation of KLF5.

A Coordinated Phosphorylation By Lats And Ck1 Regulates Yap Stability Through Scf Beta-Trcp

to Cyclin D1 Overexpression in Human Cancer

Ubiquitylation of unphosphorylated c-myc by novel E3 ligase SCFFbxl8

Abstract 4962: Discovery of Cancer-Specific E3 Ligase Ligands for Targeted Protein Degradation

KDM2B/FBXL10 Targets C-Fos for Ubiquitylation and Degradation in Response to Mitogenic Stimulation

Proteomic Identification of Common SCF Ubiquitin Ligase FBXO6-interacting Glycoproteins in Three Kinds of Cells.

Mechanisms and function of substrate recruitment by F-box proteins

Quantitative Phosphoproteomic Analysis Reveals System-Wide Signaling Pathways Downstream of Sdf-1/Cxcr4 in Breast Cancer Stem Cells

Fbxo22 promotes cervical cancer progression via targeting p57Kip2 for ubiquitination and degradation

The Scffbw7 E3 Ubiquitin Ligase Complex Targets Klf5 For Ubiquitination And Degradation In A Phosphorylation Dependent Manner

The Skp2 Pathway: A Critical Target for Cancer Therapy

The N-terminal Phosphodegron Targets TAZ/WWTR1 Protein for SCFβ-TrCP-dependent Degradation in Response to Phosphatidylinositol 3-Kinase Inhibition

Phosphorylation regulates cullin-based ubiquitination in tumorigenesis

SKP2-mediated FBXO2 proteasomal degradation drives hepatocellular carcinoma progression via stabilizing Hsp47

Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover